NYSEAMERICAN:BVX

Bovie Medical (BVX) Stock Price, News & Analysis

$6.48
+0.07 (+1.09%)
(As of 12/31/2018)
Today's Range
$6.35
$6.71
50-Day Range
N/A
52-Week Range
$2.28
$7.70
Volume
129,500 shs
Average Volume
136,878 shs
Market Capitalization
$215.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BVX stock logo

About Bovie Medical Stock (NYSEAMERICAN:BVX)

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

BVX Stock Price History

BVX Stock News Headlines

Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Bovie Medical earnings: here's what Wall Street expects
MEDICAL MYSTERIES
Bovie Medical (BVX) Looks Good: Stock Moves 9.1% Higher
See More Headlines
Receive BVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bovie Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2018
Today
4/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:BVX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$215.14 million
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Charles D. Goodwin
    President, Chief Executive Officer & Director
  • Matthew C. Hill
    Chief Financial & Accounting Officer
  • Shawn D. Roman
    Director-Research & Development
  • Kari Larson
    Senior Director-Clinical Affairs
  • Todd Hornsby
    Executive Vice President

BVX Stock Analysis - Frequently Asked Questions

How were Bovie Medical's earnings last quarter?

Bovie Medical Co. (NYSEAMERICAN:BVX) announced its quarterly earnings results on Thursday, November, 1st. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.08. The medical device company earned $3.67 million during the quarter, compared to analyst estimates of $3.67 million. Bovie Medical's quarterly revenue was up 38.5% on a year-over-year basis. During the same period last year, the firm earned ($0.09) EPS.

What other stocks do shareholders of Bovie Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bovie Medical investors own include Geron (GERN), AbbVie (ABBV), ENGlobal (ENG), Airgain (AIRG), Liquidity Services (LQDT), A.H. Belo (AHC), AMAG Pharmaceuticals (AMAG), Antares Pharma (ATRS), Ceragon Networks (CRNT) and Genetic Technologies (GENE).

How do I buy shares of Bovie Medical?

Shares of BVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:BVX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners